AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Automated algorithms to characterize myocardial optical coherence tomography imaging

Summary

Despite risks of complication and suboptimal diagnostic yield, endomyocardial biopsy (EMB), an invasive procedure in which a piece of heart tissue is extracted and analyzed, remains the gold standard for diagnosing unexplained myocardial disease. Currently, EMB is performed by randomly sampling myocardial tissue. This tissue is then examined under a microscope for diagnosis. The diagnostic yield of the procedure is low because a relatively small area of the heart is sampled. Alternatively, increasing the number of samples increases cardiac scarring, which is also undesirable. This technology describes a non-invasive method of imaging over large areas of the heart that can be used to provide more information than EMB alone. This technology could be used by research laboratories and academic institutions to improve the detection of heart transplant rejection and cardiomyopathies, as well as provide information regarding the outcomes of treatment decisions and new therapy options.

Technology Benefits

Decreases the number of tissue samples requiredIncreases the diagnostic yield of tissue samplingAllows clinician to avoid biopsy of important structuresTech Ventures Reference: IR CU14291

Technology Application

Cardiac tissue samplingMonitoring atherosclerotic and hypertrophic cardiovascular changesMonitoring heart transplant rejection

Detailed Technology Description

None

Country/Region

USA

For more information, please click Here